| 【Objective】In patients with re-IVF-embryo transplantation(In vitro fertilization and embryo transfer,IVF-ET)antagonist,we observed pregnancy outcome,including clinical pregnancy rate,biochemical pregnancy rate,improvement of early pregnancy and primary and secondary syndrome.【Method】Patients with low prognosis of kidney Yin deficiency liver depression and blood stasis of Sichuan Provincial People’s Hospital from February 2019 to December 2019 and West China Second University Hospital from January 2020 to February 2021,By randomized into treatment and control groups,For 110 cases,Actually 103 cases,Among them,50 cases were included in the treatment group;In 53 cases in the control group,the treatment group was guided by oral dehydrophenoandrosterone +oral administration of Traditional Chinese medicine+ear acupoint pressure+Taditional Chinese medicine enema for 3 months;The control group gave oral DHEA 3 months,Both groups of patients promoted ovulation with an antagonist regimen after 3 months,Embryo transfer,Lutesome support after transplantation.Observe the pregnancy outcomes after the two groups of embryo transplantation,including the clinical pregnancy rate,biochemical pregnancy rate,ectopic pregnancy rate,early abortion rate,and the improvement of TCM syndrome before and after treatment.【Results】1.This study initially found that the pregnancy outcome of another IVF-ET,clinical pregnancy,early abortion(P <0.05),biochemical pregnancy(P> 0.05)and ET daily endometrial thickness(P <0.05);2.This study initially found that after the multimodal intervention of TCM,the treatment group improved,the number of TCM syndrome(P <0.05)and most of the secondary syndrome(P <0.05).【Conclusion】Patients with TCM multimodal intervention and low IVF-ET can improve their clinical pregnancy rate and improve pregnancy outcome;improve the performance of kidney Yin deficiency and blood stasis,reduce the TCM syndrome score. |
PDF Full Text Request